Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 138

Sort by

Sort Order Select

Journal Articles

Trephine Immuno-Histochemistry As an Useful Adjunct in Characterizing Myelonecrosis in Resource Poor Settings - a Study from India

Shruti Mishra, MBBS, MD PDF Hematology, Somanath Padhi, MBBS MD, Rasheeda Mohamedali, MBBS, Kishore Kumar, MBBS, MD DM

Blood (2019) 134 (Supplement_1): 5028.

https://doi.org/10.1182/blood-2019-128772

Published: 2019

Journal Articles

Amyloidosis and Plasma Cell Dyscrasias: A Single Institution Experience

Poornima Ramadas, MBBS, Ajay Tambe, MBBS, Mijung Lee, MD

Blood (2019) 134 (Supplement_1): 5463.

https://doi.org/10.1182/blood-2019-131577

Published: 2019

Journal Articles

Localized Pulmonary Amyloidosis: A Single Institution Experience

Ajay Tambe, MBBS, Poornima Ramadas, MBBS, Mijung Lee, MD, Kanish Mirchia, MD

Blood (2019) 134 (Supplement_1): 5464.

https://doi.org/10.1182/blood-2019-125124

Published: 2019

Journal Articles

Utilizing Multiparametric Flow Cytometry to Identify Patients with Primary Plasma Cell Leukemia at Diagnosis

Blood (2019) 134 (Supplement_1): 4334.

https://doi.org/10.1182/blood-2019-126777

Published: 2019

Journal Articles

In Vitro and in Vivo Activity of Melflufen in Amyloidosis

Ken Flanagan, PhD, Muntasir M Majumder, MSc, BPharm, Romika Kumari, PhD, Juho Miettinen, PhD, Ana Slipicevic, PhD, Sarah A. Holstein, MD PhD, Michelle L. Varney, MS, Minna Suvela, MSC, Fredrik Lehmann, PhD, Nina N. Nupponen, PhD, Caroline A Heckman, PhD

Blood (2019) 134 (Supplement_1): 3100.

https://doi.org/10.1182/blood-2019-125952

Published: 2019

Journal Articles

Comparison of the Performance of Surface Alone or Surface Plus Cytoplasmic Approaches for the Assessment of Minimal Residual Disease in Multiparameter Flow Cytometry in Multiple Myeloma

Marie C Bene, PharmD,DPhil, Nelly Robillard, PhD, Philippe Moreau, MD, Soraya Wuilleme, PharmD, PhD

Blood (2019) 134 (Supplement_1): 1799.

https://doi.org/10.1182/blood-2019-130607

Published: 2019

Journal Articles

A Prospective Observational Study of Clinico-Pathological Features, Prognostic Factors and Treatment Response to Primary Therapy in Multiple Myeloma at a Tertiary Care Centre

Saurabh Mishra, MD DNB, Ashok K Vaid, MDDM, Nitin Sood, MDFRCPath,MRCP, Manorama Bhargava, Bhuvan Chugh, DNB, Roshan Dixit, MD, Amrita Ramaswami, MDDM, Devender Sharma, MD

Blood (2019) 134 (Supplement_1): 5559.

https://doi.org/10.1182/blood-2019-125752

Published: 2019

Journal Articles

Establishment and Characterization of a Myeloma Cell Line- Aku-MY01

Sheerien Kareem Rajput, BSc,MSc, El-Nasir M A Lalani, BSc MBChB FRCPath PhDFHEA

Blood (2019) 134 (Supplement_1): 5535.

https://doi.org/10.1182/blood-2019-132238

Published: 2019

Journal Articles

V(D)J Sequence Capture for DNA-Based Minimal Residual Disease Detection in Multiple Myeloma

Even H Rustad, MD, Malin Hultcrantz, MD PhD, Venkata D Yellapantula, Theresia Akhlaghi, BS, Caleb Ho, MD, Maria E Arcila, MD, Mikhail Roshal, MD PhD, Akshar Patel, BA, Sean M Devlin, PhD, Austin Jacobsen, Ying Huang, PhD, Jeffrey E Miller, PhD, Elli Papaemmanuil, PhD, Ola Landgren, MD PhD

Blood (2018) 132 (Supplement 1): 4444.

https://doi.org/10.1182/blood-2018-99-113889

Published: 2018

Journal Articles

The Diagnostic Value of Kappa/Lambda Ratios Determined By Flow Cytometric Analysis of Peripheral Blood and Bone Marrow Specimens in B-Cell Chronic Proliferative Disease

Aldair Sousa Paiva, PhD, Alessandra Suelen Jardim, Victor lima Soares, Hugo Diogenes De Oliveira Paiva, MD, Frank Bahia, MD, Valéria SF Sales, PhD, Marcos Dias Leão, PhD, Antonia Eduarda Martins Oliveira Elói Silva, João Pedro Andrade Lima, Geraldo Barroso Cavalcanti, Jr., PhD

Blood (2018) 132 (Supplement 1): 5431.

https://doi.org/10.1182/blood-2018-99-119868

Published: 2018

Journal Articles

Contribution of Flow Cytometry Immunophenotyping in Diagnostic of Acute and Chronic Leukemias

Aldair Sousa Paiva, PhD, Hugo Diogenes De Oliveira Paiva, MD, Geraldo Barroso Cavalcanti, Jr., PhD, Lenilton Silva Silveira, Jr., MD, Lorena KF Silva, Erica Aires Gil, MD, Roberto C Vasconcelos, MD, Frank Bahia, MD, Rodrigo Villar Freitas, MD, Dany GKC Silva, Valéria SF Sales, PhD, Alessandra Suelen Jardim, Victor lima Soares, James Farley Marciel

Blood (2018) 132 (Supplement 1): 5198.

https://doi.org/10.1182/blood-2018-99-118923

Published: 2018

Journal Articles

Survival Outcomes of Young Multiple Myeloma Patients: A Single Center Experience

Pelin Aytan, MD, Mahmut Yeral, MD, Cigdem Gereklioglu, MD, Aslı Korur, MD, Funda Tanrıkulu, MD, Soner Solmaz, MD, Nurhilal Buyukkurt, MD, Mutlu Kasar, MD, Suheyl Asma, MD, Can Boga, MD, Ilknur Kozanoglu, MD, Hakan Ozdogu, MD

Blood (2018) 132 (Supplement 1): 5766.

https://doi.org/10.1182/blood-2018-99-118516

Published: 2018

Journal Articles

Cases of Extra- Medullary Myeloma Presenting As Liver Infiltrates: A Single Community Hospital Experience

Yang Yang, Sorab Gupta, MD, Rashmika Potdar, MBBS, Mark S Morginstin, DO, Gabor Varadi, MD

Blood (2018) 132 (Supplement 1): 5644.

https://doi.org/10.1182/blood-2018-99-117720

Published: 2018

Journal Articles

FISH Abnormalities (including R-ISS defining and IgH mutations) Are Similar across Race and Ethnicity Among Patients with Multiple Myeloma (except higher rates of t(4:14) in Minorities and 1q Amplifications in Asian/Indians)

Noa Biran, MD, Camille Johnson, MD, Andrew D Norden, MD MPH MBA, Roger Kumar, BS MS, David H. Vesole, MD PhD, Seth H. Berk, MD, Denis B. Fitzgerald, MD, David S Siegel, MD PhD, Stuart L. Goldberg, MD

Blood (2018) 132 (Supplement 1): 5608.

https://doi.org/10.1182/blood-2018-99-119744

Published: 2018

Journal Articles

Clinical Characteristics and Outcome of Patients with Wild-Type Transthyretin and AL Cardiac Amyloidosis Confirmed By Mass Spectrometry

Stephen Parkin, MD BSc, Michael A. Seidman, MD FRCPC, Margot Davis, MD FRCPC, Kevin Song, MD

Blood (2018) 132 (Supplement 1): 3126.

https://doi.org/10.1182/blood-2018-99-115317

Published: 2018

Journal Articles

Analysis of T-Cell Receptor Beta-Constant Region Expression for Rapid Assessment of T-Cell Clonality

Paul Maciocia, BSc, MBChB, MRCP, Margarida Neves, MSc, Shimobi Onuoha, PhD, Patrycja Wawrzyniecka, Giuseppe Gritti, Manuela Tosi, Alessia Moioli, Martin Pule, MD, Teresa Marafioti, MD

Blood (2018) 132 (Supplement 1): 2867.

https://doi.org/10.1182/blood-2018-99-112569

Published: 2018

Journal Articles

Isoprenoid Amide Bisphosphonates As a Novel Class of Geranylgeranyl Diphosphate Synthase Inhibitors

Michelle L. Varney, MS, Daniel B. Goetz, BA, David F. Wiemer, PhD, Sarah A. Holstein, MD PhD

Blood (2018) 132 (Supplement 1): 4679.

https://doi.org/10.1182/blood-2018-99-112965

Published: 2018

Journal Articles

Progression Free Survival below 12 Months Following Stem Cell Transplant Is a Hallmark of High-Risk Myeloma Which Is Associated with Inferior Overall Survival — Data from the Ukmrc Myeloma XI Trial

Blood (2018) 132 (Supplement 1): 122.

https://doi.org/10.1182/blood-2018-99-111117

Published: 2018

Journal Articles

Seeking AL Amyloidosis Very Early: The SAVE Trial — Identifying Clonal Lambda Light Chain Genes in Patients with MGUS or Smoldering Multiple Myeloma

Ping Zhou, MD PhD, Adin Kugelmass, BSc, Denis Toskic, Melissa Warner, BS, Lisa X. Lee, MD, Teresa Fogaren, NP, Cindy Varga, MD BSc, Raymond L Comenzo, MD

Blood (2018) 132 (Supplement 1): 1903.

https://doi.org/10.1182/blood-2018-99-112902

Published: 2018

Journal Articles

Evaluation of Re-Intensification of Daratumumab to Weekly or Biweekly Dosing Schedule

Elaine Xiang, PharmD, Hillary Prescott, PharmD, Jacob Laubach, MD, Paul Richardson, Kaitlen Reyes, NP, Irene M. Ghobrial, MD, Houry Leblebjian, PharmD

Blood (2018) 132 (Supplement 1): 2024.

https://doi.org/10.1182/blood-2018-99-111191

Published: 2018

NARROW

Trephine Immuno-Histochemistry As an Useful Adjunct in Characterizing Myelonecrosis in Resource Poor Settings - a Study from India

Amyloidosis and Plasma Cell Dyscrasias: A Single Institution Experience

Localized Pulmonary Amyloidosis: A Single Institution Experience

Utilizing Multiparametric Flow Cytometry to Identify Patients with Primary Plasma Cell Leukemia at Diagnosis

In Vitro and in Vivo Activity of Melflufen in Amyloidosis

Comparison of the Performance of Surface Alone or Surface Plus Cytoplasmic Approaches for the Assessment of Minimal Residual Disease in Multiparameter Flow Cytometry in Multiple Myeloma

A Prospective Observational Study of Clinico-Pathological Features, Prognostic Factors and Treatment Response to Primary Therapy in Multiple Myeloma at a Tertiary Care Centre

Establishment and Characterization of a Myeloma Cell Line- Aku-MY01

V(D)J Sequence Capture for DNA-Based Minimal Residual Disease Detection in Multiple Myeloma

The Diagnostic Value of Kappa/Lambda Ratios Determined By Flow Cytometric Analysis of Peripheral Blood and Bone Marrow Specimens in B-Cell Chronic Proliferative Disease

Contribution of Flow Cytometry Immunophenotyping in Diagnostic of Acute and Chronic Leukemias

Survival Outcomes of Young Multiple Myeloma Patients: A Single Center Experience

Cases of Extra- Medullary Myeloma Presenting As Liver Infiltrates: A Single Community Hospital Experience

FISH Abnormalities (including R-ISS defining and IgH mutations) Are Similar across Race and Ethnicity Among Patients with Multiple Myeloma (except higher rates of t(4:14) in Minorities and 1q Amplifications in Asian/Indians)

Clinical Characteristics and Outcome of Patients with Wild-Type Transthyretin and AL Cardiac Amyloidosis Confirmed By Mass Spectrometry

Analysis of T-Cell Receptor Beta-Constant Region Expression for Rapid Assessment of T-Cell Clonality

Isoprenoid Amide Bisphosphonates As a Novel Class of Geranylgeranyl Diphosphate Synthase Inhibitors

Progression Free Survival below 12 Months Following Stem Cell Transplant Is a Hallmark of High-Risk Myeloma Which Is Associated with Inferior Overall Survival — Data from the Ukmrc Myeloma XI Trial

Seeking AL Amyloidosis Very Early: The SAVE Trial — Identifying Clonal Lambda Light Chain Genes in Patients with MGUS or Smoldering Multiple Myeloma

Evaluation of Re-Intensification of Daratumumab to Weekly or Biweekly Dosing Schedule

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only